Clinical Trial Update: Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trials in Japan evaluated the efficacy and safety of alogliptin in combination with metformin for type 2 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-07-11